Federal Government: Mylan Has Been Overcharging for EpiPens

Even the federal government is apparently paying too much for EpiPens, along with angry patients and insurers.

The skyrocketing price of the life-saving allergy shot, which has triggered a storm of criticism, is only part of the problem. Now the federal government, responding to Congressional inquiries, says Medicaid has for years been paying too much for EpiPens because the emergency shot is classified incorrectly as a generic medicine.

The federal government says EpiPen is a branded drug, which means the drug’s maker, Mylan, should have been paying the government a far higher rebate under the government’s complex pricing rules. Mylan could face steep penalties.

Mylan, which has been blasted for hiking EpiPen’s price to $608 from $94 since 2007, denies wrongdoing.

 

Copyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 

Comments

Leave a Reply

Please log in using one of these methods to post your comment:

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

More From CBS Tampa

Kids Rock Science presented by Tampa Bay Water - A STEM Event at MOSIClick here to inquire about becoming our STEM sponsor!
Gasparilla 2017: Invasion, Pirates, Parade & Parking By The NumbersAs the January 28th, 2017 Gasparilla Pirate Festival nears, the pirates are preparing for one crazy invasion. Here is a look at this year's festival by the numbers.

Listen Live